A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : lcSSc / limited cutaneous SSc

[Related PubMed/MEDLINE]
Total Number of Papers: 121
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   lcSSc  (>> Co-occurring Abbreviation)
Long Form:   limited cutaneous SSc
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis. Ab, dcSSc, HCs, HP, SSc
2020 Autoantibody profile in a cohort of Algerian patients with systemic sclerosis. ATA, dcSSc, ILD, PAH, SSc
2020 Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. dcSSc, FC, GEE, HR, mRSS, PF, SSc
2020 Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study. dcSSc, ILD, mRSS
2020 Exploring the feasibility of an exercise programme including aerobic and resistance training in people with limited cutaneous systemic sclerosis. QOL, SSc
2020 microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients. dcSSc, miRNAs, PBMCs, SSc, survivin-WT
2020 State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders. AU, PRP, SSc, UCTD
2020 Ultrasound assessment of skin thickness and stiffness: the correlation with histology and clinical score in systemic sclerosis. dcSSc, mRSS, SSc, SWE
2020 Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. dcSSc, PF, PH, SRC, SSc
10  2019 Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? alpha-SMA, anti-Cenp-B, anti-Topo-I, Col-I, ENAs, ICC, qPCR, SSc
11  2019 Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets. dcSSc, SSc
12  2019 Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis : An updated meta-analysis. CI, dcSSc, SMRs, SSc
13  2019 Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. dcSSc, EUSTAR, SSc
14  2018 Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry. dcSSc, HBI, PBC, SSc, SSc-HBI, ssSSc
15  2018 High Prevalence of Antithyroid Antibodies in a New Zealand Cohort of Patients With Systemic Sclerosis. anti-Tg, anti-TPO, ATAs, SOS, SSc
16  2018 Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. dcSSc, FVC, HRCT, ILD, SSc, ssSSc
17  2018 Oxidative stress in the pathogenesis of systemic scleroderma: An overview. dcSSc, ROS, SSc
18  2018 Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function. dcSSc, DU, GDF15, ILD, PlGF, PTX3, RHI, RVSP, SSc, VEGF
19  2018 Prevalence and predictors of hand involvement in Thai patients with systemic sclerosis. dcSSc, mRSS, SSc
20  2018 Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis. dcSSc, RF, SOS, SSc
21  2018 Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. dcSSc, SMR, SSc
22  2018 The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis. CTDs, dcSSc, ILD, SF, SSc, THEs, vWF, VWFpp
23  2017 Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. dcSSc, EUSTAR, RP, sPAP, SSc, TTE
24  2017 Disease-related autoantibody profile in patients with systemic sclerosis. anti-CENP, autoAbs, CENP-A, CENP-B, dcSSc, ILD, PDGFR, PH, RP, SSc
25  2017 Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum. dcSSc, EaSSc, SSc, TNFRII
26  2017 Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis. ARA, ATA, dcSSc, ILD, SSc
27  2017 Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature. CVS, DEG, HC, SAM, TGF
28  2017 Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor beta and Activate Fibroblasts. dcSSc, IL-6, IL-6R, SSc, TGF-beta
29  2017 Stem cells therapy: the future in the management of systemic sclerosis? A case report. ADSCs, ADSVF, dcSSc, MSCs, PLA, SSc
30  2016 Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. ATA, dcSSc, OR, RP, SSc
31  2016 Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc). SSc, TNF-alpha
32  2016 Different contributions of angiostatin and endostatin in angiogenesis impairment in systemic sclerosis: a cohort study. dcSSc, SSc
33  2016 Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. dcSSc, DU, RESCLE, SSc, ssSSc
34  2016 Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study. dcSSc, HR, HRCT, ILD, IR
35  2016 Presence of organ‑specific antibodies in patients with systemic sclerosis. ACAs, AMAs, ATDs, dcSSc, PBC, SSc
36  2016 Serum level of circulating syndecan-1: A possible association with proliferative vasculopathy in systemic sclerosis. dcSSc, SSc
37  2016 Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. dcSSc, SSc
38  2015 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. MCP
39  2015 Airway resistance and reactance are affected in systemic sclerosis. dcSSc, HRCT, IOS, SSc
40  2015 Evaluation of right ventricular function performed by 3D-echocardiography in scleroderma patients. 2DSTE, 3DE, dcSSc, PAH, RV, sPAP, SSc, TPVR
41  2015 Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis. dcSSc, EC, sST2
42  2015 Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis. dcSSc, HC, IL, MCP, PDGF, SSc
43  2015 T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review. dcSSc, NK, PB, Th
44  2015 The global peripheral chemoreflex drive in patients with systemic sclerosis: a rebreathing and exercise study. CPET, dcSSc, EI, GPCD, SSc
45  2014 A study on pulmonary complications of systemic sclerosis in eastern India. ANA, dcSSc, DLCO, DPLD, HRCT, PAH, PASP, SSc
46  2014 Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis. dcSSc, LOX, MRSS, SSc
47  2014 Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. dcSSc, FMD, SSc
48  2014 Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. dcSSc, HAD, HRQoL, SSc
49  2014 Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis. PBC, SSc, TGF-beta
50  2014 Prediction of pulmonary complications and long-term survival in systemic sclerosis. dcSSc, PF, PH, SSc
51  2014 Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype. dcSSc, SSc
52  2014 Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience. 6MWD, dcSSc, PAH, SSc, SSc-PAH
53  2014 Serum levels of soluble carbonic anhydrase IX are decreased in patients with diffuse cutaneous systemic sclerosis compared to those with limited cutaneous systemic sclerosis. CAIX, dcSSc, SSc, SSD
54  2013 Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosis. dcSSc, FMD, SSc
55  2013 Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis. dcSSc, RBP4, SSc
56  2013 Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis. dcSSc, DMECs, SSc, sTie1
57  2013 HLA markers for poor prognosis in systemic sclerosis Brazilian patients. dcSSc, HLA, PR, SSc
58  2013 Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. dcSSc, RAGE, SSc
59  2013 Risk factors for body composition abnormalities in systemic sclerosis. BC, BMD, BMI, FM, RSMI, SSc
60  2013 STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. ATA, dcSSc, SNPs, SSc
61  2012 A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis. CTSB, dcSSc, HDMECs, SSc, TGF-beta
62  2012 Assessment of capillary density in systemic sclerosis with three different capillaroscopic methods. dcSSc, SSc
63  2012 Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. CRP, dcSSc, ESR, mRSS, OR
64  2012 Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts? dcSSc, IQR, RP, SSc
65  2012 Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. dcSSc, ILD, ssSSc
66  2012 Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis. dcSSc, ELISA, SSc
67  2012 Serum levels of soluble CD21 in patients with systemic sclerosis. dcSSc, sCD21, SSc
68  2012 The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory study. COPE, dcSSc, lSSc, SSc
69  2012 The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile. DAS, dcSSc, DSS, lSSc, SSc
70  2011 A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. ACA, OR, PAH, SSc, uPAR
71  2011 A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. ACA, SSc
72  2011 Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients. dcSSc
73  2011 Clinical and serological hallmarks of systemic sclerosis overlap syndromes. ACA, RA, RF, SLE, SS, SSc
74  2011 Diagnosis and classification of systemic sclerosis. CREST, dcSSc, lSSc, SSc
75  2011 Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. IFN, IL-13, PAH, PBMCs, SSc
76  2011 Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations. dcSSc, SSc
77  2010 Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. ILD, IP, RNAP III
78  2010 Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. dcSSc, MMP-12, SSc
79  2010 Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors. GAVE, RNAP, SSc
80  2010 Gastrointestinal involvement in patients with systemic sclerosis. dcSSc, GI, SSc
81  2010 Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. dcSSc, SSc
82  2009 A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. ADL, dcSSc, FS, HAMIS, mRSS, RP, SSc, VAS
83  2009 Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. dcSSc, IL-13, SSc
84  2009 Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis. ACh, dcSSc, ET-1, SNP, SSc
85  2009 Renal function is mostly preserved in patients with systemic sclerosis. 51Cr-EDTA, ACR, dcSSc, GFR, SRC, SSc
86  2009 The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. dcSSc, ILD, sFas, SNP, SSc
87  2009 The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes. ORs, SSc
88  2009 The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. CI, dcSSc, OR, SSc
89  2008 Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. dcSSc, FITF, IL-2, MDR, SSc
90  2008 Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. dcSSc, IFN, IL-10, IL-10R2, SSc
91  2008 Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. dcSSc, mRNA, SSc
92  2008 Prevalence and predictors of pulmonary artery hypertension in systemic sclerosis. dcSSc, PAH, SSc
93  2007 Anticentromere antibodies identify patients with Sjogren's syndrome and autoimmune overlap syndrome. ACA, pSS, SSc
94  2007 Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. CHFS, dSSc, HAQ, sHAQ, SSc
95  2007 Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis. SNP, SSc
96  2007 Clinical diagnosis compared to classification criteria in in a cohort of 54 patients with systemic sclerosis and associated disorders. dcSSc, lSSc, MCTD, RP, RS, SSc
97  2007 Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. anti-topo I, dcSSc, MRSS, STPRs
98  2007 Health values of patients with systemic sclerosis. CES-D, dcSSc, DI, HAQ, MCS, PCS, RS, SF-36, SG, SSc, TTO, VAS
99  2007 Increased serum soluble CD40 levels in patients with systemic sclerosis. dcSSc, sCD40, SSc
100  2007 Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis. dcSSc, IL-10, OR, SSc